Schedule 13D



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


SCHEDULE 13D
Under the Securities Exchange Act of 1934

(Amendment No. 2)

VistaCare, Inc.
(Name of Issuer)

Class A Common Stock, par value $0.01 per share
(Title of Class of Securities)

92839Y109
(CUSIP Number)

Simon M. Lorne, Esq.
Millennium Management LLC
666 Fifth Avenue, 8th Floor
New York, New York 10103
(212) 841-4100
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

December 21, 2007
(Date of event which requires filing of this statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because § 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g) check the following box o .


SCHEDULE 13D

CUSIP No. 92839Y109
1
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

Millenco LLC
13-3532932
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)   o
(b)   þ
3
SEC USE ONLY
4
SOURCE OF FUNDS

WC, OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

 
þ
6
CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER

-0-
8
SHARED VOTING POWER

1,629,299 (See Item 6)
 
9
SOLE DISPOSITIVE POWER

-0-
 
10
SHARED DISPOSITIVE POWER

1,629,299 (See Item 6) 

11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,629,299 (See Item 6)

12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.7%
14
TYPE OF REPORTING PERSON

OO, BD

SCHEDULE 13D

CUSIP No. 92839Y109
1
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

Millennium Management LLC
13-3804139
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)   o
(b)   þ
3
SEC USE ONLY
4
SOURCE OF FUNDS

WC, OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

 
þ
6
CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER

-0-
8
SHARED VOTING POWER

1,629,299 (See Item 6)
 
9
SOLE DISPOSITIVE POWER

-0-
 
10
SHARED DISPOSITIVE POWER

1,629,299 (See Item 6) 

11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,629,299 (See Item 6)

12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

9.7%
14
TYPE OF REPORTING PERSON

OO

SCHEDULE 13D

CUSIP No. 92839Y109
1
NAMES OF REPORTING PERSONS.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).

Israel A. Englander
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)   o
(b)   þ
3
SEC USE ONLY
4

SOURCE OF FUNDS


WC, OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

þ

6
CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER

-0-

8
SHARED VOTING POWER

1,629,299 (See Item 6) 
9
SOLE DISPOSITIVE POWER
 
-0- 
10
SHARED DISPOSITIVE POWER

1,629,299 (See Item 6) 

11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,629,299 (See Item 6)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
9.7%
14
TYPE OF REPORTING PERSON
 
IN

Explanatory Note  

Introduction

   This Amendment No. 2 to Schedule 13D ("Amendment No. 2 to Schedule 13D") amends Amendment No. 1 to Schedule 13D filed on November 16, 2007 ("Amendment No. 1 to Schedule 13D") by the Reporting Persons (as defined in Item 2, below), relating to their beneficial ownership of the Class A Common Stock (as defined in Item 1, below) of VistaCare, Inc. (the "Issuer").

   Amendment No. 2 to Schedule 13D (i) amends and restates Item 3 and Item 5 and (ii) reflects a material change in the number of shares beneficially owned by each Reporting Person and the percentage of class represented by such ownership since the filing of Amendment No. 1 to Schedule 13D for each Reporting Person. Except for the above-referenced amendments, Amendment No. 2 to Schedule 13D does not modify any of the information previously reported on Amendment No. 1 to Schedule 13D.

Item 1.      Security and Issuer.

   The name of the Issuer is VistaCare, Inc., a Delaware corporation. The address of the Issuer’s offices is 4800 North Scottsdale Road, Suite 5000, Scottsdale, Arizona 85251. This Amendment No. 2 to Schedule 13D relates to the Issuer’s Class A common stock, par value $0.01 per share (the "Class A Common Stock").

Item 2.      Identity and Background.

   (a)-(c), (f).  This statement is being filed by Millenco LLC, a Delaware limited liability company (formerly Millenco, L.P., a Delaware limited partnership) ("Millenco"). Millenco is a broker-dealer and a member of the American Stock Exchange and the NASDAQ. Millennium Management LLC, a Delaware limited liability company ("Millennium Management"), is the manager of Millenco, and consequently may be deemed to have voting control and investment discretion over securities owned by Millenco. Israel A. Englander ("Mr. Englander") is the managing member of Millennium Management. As a result, Mr. Englander may be deemed to be the beneficial owner of any shares deemed to be beneficially owned by Millennium Management. The foregoing should not be construed in and of itself as an admission by Millennium Management or Mr. Englander as to beneficial ownership of the shares owned by Millenco. Millenco, Millennium Management and Mr. Englander will be collectively referred to as the reporting persons ("Reporting Persons") in this Amendment No. 2 to Schedule 13D.

   The business address for Millenco, Millennium Management and Mr. Englander is c/o Millennium Management LLC, 666 Fifth Avenue, New York, New York 10103. Mr. Englander is a United States citizen.

   Note:  Integrated Holding Group LP, a Delaware limited partnership ("Integrated Holding Group"), is a non-managing member of Millenco. As a non-managing member, Integrated Holding Group has no voting control or investment discretion over Millenco or its securities positions.

   (d)  During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

   (e)  On December 1, 2005, Millennium Management and Mr. Englander, together with Millennium Partners, L.P. ("Millennium Partners") and certain related persons and entities, entered into settlements with the Securities and Exchange Commission ("SEC") and the Attorney General of the State of New York (the "NYAG") relating to allegations that Millennium Partners had engaged in a pattern of deceptive "market timing" of mutual fund shares in years prior to 2004 and, in the case of the settlement with the NYAG only, had failed to take adequate steps to prevent a trader from engaging in mutual fund "late trading" in violation of firm policy. The parties neither admitted nor denied the allegations or findings (except as to jurisdiction) but consented to the entry of findings. The SEC proceedings are In the Matter of Millennium Partners, L.P., et al. Securities Act Release No. 8639 (December 1, 2005), available at www.sec.gov. Contemporaneously, the NYAG issued an Assurance of Discontinuance relating to the claims and findings of that office.

   Neither the Reporting Persons nor any other party admitted or denied any of the allegations or findings in these matters. The remedies included disgorgement by the entities of approximately $148 million of mutual fund trading profits, civil penalties aggregating approximately $32.15 million (with approximately $30 million being paid by Mr. Englander), an administrative order to cease and desist from violations of the antifraud provisions of the Securities Act of 1933 and the Securities Exchange Act of 1934 (the "Exchange Act"), and prophylactic relief.

Item 3.      Source and Amount of Funds or Other Consideration.

   The amount of funds used to purchase the 1,629,299 shares of the Issuer’s Class A Common Stock held by Millenco giving rise to this Amendment No. 2 to Schedule 13D was approximately $15,493,200, calculated on an average cost basis (excluding brokerage commissions) by account. Millenco effects purchases of securities primarily through margin accounts maintained for it with prime brokers, which may extend margin credit to Millenco as and when required to open or carry positions in the margin accounts, subject to applicable Federal margin regulations, stock exchange rules and the prime broker’s credit policies. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the accounts.

Item 4.       Purpose of Transaction.

   The Reporting Persons are engaged in the investment business. In pursuing this business, the Reporting Persons analyze the operations, capital structure and markets of companies, including the Issuer, on a continuous basis, through analysis of documentation and discussions with knowledgeable industry and market observers and with representatives of such companies (often at the invitation of management). From time to time, one or more of the Reporting Persons may hold discussions with third parties or with management of such companies in which the Reporting Persons may suggest or take a position with respect to potential changes in the operations, management or capital structure of such companies as a means of enhancing shareholder value. Such suggestions or positions may relate to one or more of the transactions specified in clauses (a) through (j) of Item 4 of Schedule 13D of the Exchange Act, including, without limitation, such matters as disposing of or selling all or a portion of the company or acquiring another company or business, changing operating or marketing strategies, adopting or not adopting certain types of anti-takeover measures and restructuring the Issuer’s capitalization or dividend policy.

   The Reporting Persons employ the services of a number of portfolio managers, each of whom independently employs a separate and distinct trading strategy. A portion of the securities of the Issuer held by the Reporting Persons are held in accounts of the Reporting Persons managed by portfolio managers who engage in event-, risk- or merger-arbitrage or fundamental strategies.

   Except as set forth above, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the actions required to be described in Item 4 of Schedule 13D. Each of the Reporting Persons may, at any time, review or reconsider its position with respect to the Issuer and formulate plans or proposals with respect to any of such matters, but has no present intention of doing so.

Item 5.      Interest in Securities of the Issuer.

   (a)  As the date hereof, Millenco held 1,629,299 shares of the Issuer’s Class A Common Stock, which represents approximately 9.7% of the outstanding shares of Class A Common Stock. The calculation of the foregoing percentage is on the basis of 16,867,692 shares of the Issuer’s Class A Common Stock outstanding as of December 4, 2007, as disclosed by the Issuer in its Form 10-K, dated December 11, 2007.

   (b)  Millenco may be deemed to hold shared power to vote and to dispose of the 1,629,299 shares of Class A Common Stock described in (a) above. Mr. Englander and Millennium Management may be deemed to hold shared power to vote and to dispose of the 1,629,299 shares of Class A Common Stock described in (a) above

   The foregoing should not be construed in and of itself as an admission by Millennium Management or Mr. Englander as to beneficial ownership of the shares owned by Millenco.

   (c)  Transactions in the Issuer’s Class A Common Stock since November 15, 2007, the date of Amendment No. 1 to Schedule 13D: Schedule A annexed hereto lists all transactions in the Issuer’s Class A Common Stock since November 15, 2007, the date of Amendment No. 1 to Schedule 13D. All of the transactions in the Issuer’s Class A Common Stock were effected by Millenco in the open market.

   (d)  No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of, dividends from, or proceeds from the sale of, the shares of Class A Common Stock reported in this Statement.

Item 6.      Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

   In connection with arrangements with Millenco’s prime brokers, such prime brokers are permitted to lend securities in Millenco’s accounts to the extent permitted by debit balances in such account. Millenco generally will not have any knowledge of the specific loans made by such prime brokers. In addition, in the ordinary course of business, Millenco (or its prime brokers), may borrow securities to satisfy delivery obligations arising from short sales and may lend securities to third parties and such loans generally may be recalled upon demand. However, it should be noted that shares lent by Millenco or its prime brokers may not be able to be recalled in advance of an applicable record date and thus, such loaned shares may not be able to be voted by Millenco.

   There are no other contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer.

Item 7.      Material to Be Filed as Exhibits.

   Exhibit I:  Joint Filing Agreement, dated as of December 24, 2007, by and among Millenco LLC, Millennium Management LLC and Israel A. Englander.


SIGNATURE

   After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: December 24, 2007

MILLENCO LLC

By: /s/ Mark Meskin

Name: Mark Meskin
Title:  Chief Executive Officer

 

MILLENNIUM MANAGEMENT LLC

By: /s/ David Nolan

Name: David Nolan
Title:  Co-President

 

/s/ Israel A. Englander by David Nolan
pursuant to Power of Attorney filed with
the SEC on June 6, 2005

Israel A. Englander



EXHIBIT I

JOINT FILING AGREEMENT

    This will confirm the agreement by and among the undersigned that the Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Class A Common Stock, par value $0.01 per share, of VistaCare, Inc., a Delaware corporation, is being filed, and all amendments thereto will be filed, on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

Dated: December 24, 2007

MILLENCO LLC

By: /s/ Mark Meskin

Name: Mark Meskin
Title:  Chief Executive Officer

 

MILLENNIUM MANAGEMENT LLC

By: /s/ David Nolan

Name: David Nolan
Title:  Co-President

 

/s/ Israel A. Englander by David Nolan
pursuant to Power of Attorney filed with
the SEC on June 6, 2005

Israel A. Englander



Schedule A

Transactions in the Issuer’s Class A Common Stock since November 15, 2007, the date of Amendment No. 1 to Schedule 13D:

Date of Transaction Quantity Purchased
(Sold)
Price Per Share
$
11/16/2007 (100) 6.89
11/16/2007 (62) 6.89
11/16/2007 (100) 6.91
11/16/2007 (100) 6.91
11/16/2007 (100) 6.91
11/16/2007 (100) 6.91
11/16/2007 (100) 6.91
11/16/2007 (100) 6.91
11/16/2007 (84) 6.91
11/16/2007 100 6.9
11/16/2007 100 6.905
11/16/2007 100 6.915
11/16/2007 100 6.92
11/16/2007 200 6.89
11/19/2007 100 6.725
11/19/2007 100 6.73
11/19/2007 100 6.73
11/19/2007 100 6.74
11/19/2007 100 6.74
11/19/2007 100 6.74
11/19/2007 100 6.74
11/19/2007 100 6.74
11/19/2007 100 6.74
11/19/2007 100 6.74
11/19/2007 100 6.74
11/19/2007 100 6.75
11/19/2007 100 6.75
11/19/2007 100 6.75
11/19/2007 100 6.75
11/19/2007 100 6.75
11/19/2007 100 6.75
11/19/2007 100 6.75
11/19/2007 100 6.75
11/19/2007 100 6.75
11/19/2007 300 6.745
11/19/2007 500 6.745
11/19/2007 800 6.745
11/20/2007 9 7.05
11/20/2007 9 7.05
11/20/2007 72 7.05
11/20/2007 91 7.05
11/20/2007 91 7.05
11/20/2007 100 6.9
11/20/2007 100 6.98
11/20/2007 100 6.99
11/20/2007 100 6.99
11/20/2007 100 6.99
11/20/2007 100 6.99
11/20/2007 100 6.99
11/20/2007 100 6.99
11/20/2007 100 6.99
11/20/2007 100 6.99
11/20/2007 100 7
11/20/2007 100 7
11/20/2007 100 7
11/20/2007 100 7
11/20/2007 100 7
11/20/2007 100 7.02
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 100 7.05
11/20/2007 200 6.99
11/20/2007 200 7
11/20/2007 200 7
11/20/2007 200 7
11/20/2007 300 7.05
11/20/2007 400 7.05
11/20/2007 600 7
11/20/2007 800 7.05
11/21/2007 12 7.24
11/21/2007 100 7.25
11/26/2007 100 7.26
11/26/2007 100 7.27
11/26/2007 100 7.28
11/26/2007 100 7.29
11/26/2007 100 7.29
11/26/2007 100 7.29
11/26/2007 100 7.3
11/26/2007 100 7.3
11/26/2007 100 7.3
11/26/2007 100 7.3
11/26/2007 100 7.31
11/26/2007 100 7.31
11/26/2007 100 7.31
11/26/2007 100 7.31
11/26/2007 100 7.31
11/26/2007 100 7.31
11/26/2007 100 7.33
11/26/2007 100 7.34
11/26/2007 100 7.37
11/26/2007 100 7.37
11/26/2007 100 7.38
11/26/2007 100 7.38
11/26/2007 100 7.39
11/26/2007 100 7.4
11/26/2007 100 7.4
11/26/2007 100 7.41
11/26/2007 100 7.41
11/26/2007 100 7.41
11/26/2007 100 7.42
11/26/2007 100 7.42
11/26/2007 100 7.42
11/26/2007 100 7.42
11/26/2007 100 7.42
11/26/2007 100 7.42
11/26/2007 100 7.42
11/26/2007 100 7.42
11/26/2007 100 7.42
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.43
11/26/2007 100 7.44
11/26/2007 100 7.44
11/26/2007 100 7.44
11/26/2007 100 7.44
11/26/2007 100 7.44
11/26/2007 100 7.44
11/26/2007 100 7.44
11/26/2007 100 7.44
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.45
11/26/2007 100 7.46
11/26/2007 100 7.46
11/26/2007 100 7.46
11/26/2007 100 7.46
11/26/2007 100 7.46
11/26/2007 100 7.46
11/26/2007 100 7.46
11/26/2007 100 7.46
11/26/2007 100 7.46
11/26/2007 100 7.46
11/26/2007 100 7.46
11/26/2007 100 7.46
11/26/2007 100 7.47
11/26/2007 100 7.47
11/26/2007 100 7.47
11/26/2007 100 7.47
11/26/2007 100 7.47
11/26/2007 100 7.47
11/26/2007 100 7.47
11/26/2007 100 7.47
11/26/2007 100 7.47
11/26/2007 100 7.48
11/26/2007 100 7.48
11/26/2007 100 7.49
11/26/2007 100 7.49
11/26/2007 100 7.49
11/26/2007 100 7.5
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.55
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.56
11/26/2007 100 7.57
11/26/2007 100 7.57
11/26/2007 100 7.57
11/26/2007 100 7.57
11/26/2007 100 7.57
11/26/2007 100 7.57
11/26/2007 100 7.58
11/26/2007 100 7.58
11/26/2007 100 7.59
11/26/2007 100 7.64
11/26/2007 100 7.64
11/26/2007 100 7.64
11/26/2007 100 7.64
11/26/2007 100 7.65
11/26/2007 100 7.65
11/26/2007 100 7.65
11/26/2007 100 7.65
11/26/2007 100 7.65
11/26/2007 100 7.65
11/26/2007 100 7.65
11/26/2007 100 7.65
11/26/2007 100 7.65
11/26/2007 200 7.39
11/26/2007 200 7.41
11/26/2007 200 7.42
11/26/2007 200 7.43
11/26/2007 200 7.44
11/26/2007 200 7.46
11/26/2007 200 7.46
11/26/2007 200 7.46
11/26/2007 200 7.5
11/26/2007 200 7.56
11/26/2007 300 7.46
11/26/2007 300 7.46
11/26/2007 300 7.46
11/26/2007 300 7.46
11/26/2007 300 7.49
11/26/2007 300 7.5
11/26/2007 500 7.45
11/26/2007 500 7.65
11/26/2007 600 7.45
11/27/2007 15,000 7.7
11/27/2007 6 7.73
11/27/2007 43 7.62
11/27/2007 57 7.61
11/27/2007 100 7.58
11/27/2007 100 7.58
11/27/2007 100 7.59
11/27/2007 100 7.59
11/27/2007 100 7.59
11/27/2007 100 7.59
11/27/2007 100 7.59
11/27/2007 100 7.59
11/27/2007 100 7.59
11/27/2007 100 7.59
11/27/2007 100 7.59
11/27/2007 100 7.61
11/27/2007 100 7.61
11/27/2007 100 7.61
11/27/2007 100 7.62
11/27/2007 100 7.64
11/27/2007 100 7.64
11/27/2007 100 7.65
11/27/2007 100 7.65
11/27/2007 100 7.66
11/27/2007 100 7.67
11/27/2007 100 7.68
11/27/2007 100 7.69
11/27/2007 100 7.7
11/27/2007 100 7.7
11/27/2007 100 7.71
11/27/2007 100 7.72
11/27/2007 100 7.72
11/27/2007 100 7.72
11/27/2007 100 7.73
11/27/2007 100 7.73
11/27/2007 100 7.73
11/27/2007 100 7.73
11/27/2007 500 7.71
12/14/2007 100 7.23
12/14/2007 100 7.23
12/14/2007 100 7.23
12/14/2007 100 7.23
12/14/2007 100 7.23
12/14/2007 100 7.23
12/14/2007 100 7.23
12/14/2007 100 7.23
12/14/2007 100 7.23
12/14/2007 100 7.2325
12/14/2007 100 7.24
12/14/2007 100 7.24
12/14/2007 100 7.24
12/14/2007 100 7.24
12/14/2007 100 7.24
12/14/2007 100 7.24
12/14/2007 100 7.24
12/14/2007 100 7.24
12/14/2007 100 7.24
12/14/2007 100 7.24
12/14/2007 100 7.25
12/14/2007 100 7.25
12/14/2007 100 7.25
12/14/2007 100 7.25
12/14/2007 100 7.25
12/14/2007 100 7.25
12/14/2007 100 7.25
12/14/2007 100 7.25
12/14/2007 100 7.25
12/14/2007 100 7.26
12/14/2007 200 7.23
12/14/2007 200 7.235
12/14/2007 200 7.235
12/14/2007 200 7.24
12/14/2007 200 7.25
12/14/2007 200 7.25
12/14/2007 200 7.25
12/14/2007 200 7.25
12/14/2007 200 7.255
12/14/2007 200 7.26
12/14/2007 200 7.26
12/14/2007 200 7.26
12/14/2007 224 7.23
12/14/2007 300 7.235
12/14/2007 300 7.24
12/14/2007 300 7.25
12/14/2007 300 7.25
12/14/2007 300 7.255
12/14/2007 300 7.255
12/14/2007 400 7.25
12/14/2007 400 7.25
12/14/2007 500 7.255
12/14/2007 1,000 7.24
12/14/2007 4,000 7.235
12/14/2007 4,000 7.24
12/18/2007 100 7.1
12/18/2007 100 7.1
12/18/2007 100 7.1
12/18/2007 100 7.1
12/18/2007 100 7.1
12/18/2007 100 7.12
12/18/2007 100 7.12
12/18/2007 100 7.12
12/18/2007 177 7.12
12/18/2007 196 7.11
12/18/2007 200 7.1
12/18/2007 227 7.1
12/18/2007 8,400 7.1
12/18/2007 15,000 7.1
12/18/2007 1 7.15
12/18/2007 6 7.2
12/18/2007 15 7.19
12/18/2007 24 7.18
12/18/2007 24 7.18
12/18/2007 26 7.19
12/18/2007 38 7.15
12/18/2007 50 7.19
12/18/2007 62 7.17
12/18/2007 76 7.18
12/18/2007 76 7.2
12/18/2007 85 7.2
12/18/2007 99 7.16
12/18/2007 100 7.095
12/18/2007 100 7.1
12/18/2007 100 7.13
12/18/2007 100 7.13
12/18/2007 100 7.14
12/18/2007 100 7.14
12/18/2007 100 7.15
12/18/2007 100 7.15
12/18/2007 100 7.15
12/18/2007 100 7.15
12/18/2007 100 7.15
12/18/2007 100 7.16
12/18/2007 100 7.16
12/18/2007 100 7.16
12/18/2007 100 7.16
12/18/2007 100 7.16
12/18/2007 100 7.16
12/18/2007 100 7.16
12/18/2007 100 7.16
12/18/2007 100 7.16
12/18/2007 100 7.165
12/18/2007 100 7.165
12/18/2007 100 7.17
12/18/2007 100 7.17
12/18/2007 100 7.17
12/18/2007 100 7.17
12/18/2007 100 7.17
12/18/2007 100 7.17
12/18/2007 100 7.17
12/18/2007 100 7.17
12/18/2007 100 7.175
12/18/2007 100 7.175
12/18/2007 100 7.175
12/18/2007 100 7.18
12/18/2007 100 7.18
12/18/2007 100 7.18
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.19
12/18/2007 100 7.2
12/18/2007 200 7.1
12/18/2007 200 7.1
12/18/2007 200 7.1
12/18/2007 200 7.14
12/18/2007 200 7.145
12/18/2007 200 7.145
12/18/2007 200 7.15
12/18/2007 200 7.155
12/18/2007 200 7.155
12/18/2007 200 7.155
12/18/2007 200 7.155
12/18/2007 200 7.17
12/18/2007 200 7.19
12/18/2007 300 7.135
12/18/2007 300 7.14
12/18/2007 300 7.19
12/18/2007 400 7.1
12/18/2007 400 7.1
12/18/2007 400 7.185
12/18/2007 400 7.185
12/18/2007 500 7.13
12/18/2007 500 7.15
12/18/2007 500 7.16
12/18/2007 500 7.16
12/18/2007 500 7.19
12/18/2007 600 7.18
12/18/2007 700 7.165
12/18/2007 700 7.19
12/18/2007 750 7.18
12/18/2007 750 7.18
12/18/2007 800 7.16
12/18/2007 900 7.19
12/18/2007 1,000 7.18
12/18/2007 1,600 7.175
12/18/2007 1,600 7.18
12/18/2007 1,800 7.195
12/18/2007 2,100 7.16
12/18/2007 2,700 7.195
12/19/2007 26 7.6
12/19/2007 26 7.61
12/19/2007 74 7.6
12/19/2007 74 7.6
12/19/2007 74 7.61
12/19/2007 100 7.33
12/19/2007 100 7.34
12/19/2007 100 7.35
12/19/2007 100 7.35
12/19/2007 100 7.35
12/19/2007 100 7.35
12/19/2007 100 7.36
12/19/2007 100 7.36
12/19/2007 100 7.36
12/19/2007 100 7.36
12/19/2007 100 7.44
12/19/2007 100 7.45
12/19/2007 100 7.45
12/19/2007 100 7.45
12/19/2007 100 7.49
12/19/2007 100 7.49
12/19/2007 100 7.5
12/19/2007 100 7.5
12/19/2007 100 7.58
12/19/2007 100 7.59
12/19/2007 100 7.59
12/19/2007 100 7.59
12/19/2007 100 7.59
12/19/2007 100 7.59
12/19/2007 100 7.59
12/19/2007 100 7.59
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.6
12/19/2007 100 7.61
12/19/2007 100 7.61
12/19/2007 100 7.61
12/19/2007 100 7.61
12/19/2007 100 7.61
12/19/2007 100 7.61
12/19/2007 100 7.61
12/19/2007 100 7.62
12/19/2007 100 7.62
12/19/2007 200 7.36
12/19/2007 200 7.59
12/19/2007 200 7.59
12/19/2007 200 7.59
12/19/2007 200 7.59
12/19/2007 200 7.59
12/19/2007 200 7.6
12/19/2007 200 7.6
12/19/2007 200 7.61
12/19/2007 200 7.61
12/19/2007 276 7.59
12/19/2007 300 7.36
12/19/2007 300 7.49
12/19/2007 300 7.5
12/19/2007 300 7.59
12/19/2007 300 7.59
12/19/2007 300 7.59
12/19/2007 300 7.6
12/19/2007 300 7.6
12/19/2007 300 7.6
12/19/2007 300 7.6
12/19/2007 300 7.61
12/19/2007 300 7.61
12/19/2007 300 7.61
12/19/2007 300 7.61
12/19/2007 300 7.62
12/19/2007 326 7.61
12/19/2007 400 7.33
12/19/2007 400 7.49
12/19/2007 400 7.6
12/19/2007 400 7.6
12/19/2007 500 7.59
12/19/2007 500 7.62
12/19/2007 500 7.62
12/19/2007 500 7.62
12/19/2007 600 7.35
12/19/2007 600 7.62
12/19/2007 918 7.34
12/19/2007 1,000 7.63
12/19/2007 1,000 7.63
12/19/2007 1,000 7.63
12/19/2007 1,300 7.36
12/19/2007 1,800 7.36
12/20/2007 100 7.45
12/20/2007 100 7.45
12/20/2007 100 7.46
12/20/2007 100 7.46
12/20/2007 100 7.46
12/20/2007 100 7.46
12/20/2007 100 7.46
12/20/2007 100 7.46
12/20/2007 100 7.46
12/20/2007 100 7.46
12/20/2007 100 7.46
12/20/2007 100 7.47
12/20/2007 100 7.47
12/20/2007 100 7.47
12/20/2007 100 7.47
12/20/2007 100 7.47
12/20/2007 100 7.47
12/20/2007 100 7.5
12/20/2007 100 7.5
12/20/2007 100 7.5
12/20/2007 100 7.51
12/20/2007 100 7.51
12/20/2007 100 7.51
12/20/2007 100 7.51
12/20/2007 100 7.51
12/20/2007 100 7.51
12/20/2007 100 7.51
12/20/2007 100 7.51
12/20/2007 100 7.51
12/20/2007 100 7.51
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 100 7.52
12/20/2007 199 7.51
12/20/2007 200 7.45
12/20/2007 200 7.46
12/20/2007 200 7.5
12/20/2007 200 7.5
12/20/2007 200 7.51
12/20/2007 200 7.51
12/20/2007 200 7.51
12/20/2007 200 7.52
12/20/2007 200 7.52
12/20/2007 200 7.52
12/20/2007 300 7.45
12/20/2007 300 7.52
12/20/2007 400 7.52
12/20/2007 500 7.52
12/20/2007 600 7.52
12/20/2007 600 7.52
12/20/2007 700 7.47
12/21/2007 50 7.71
12/21/2007 50 7.71
12/21/2007 50 7.72
12/21/2007 100 7.67
12/21/2007 100 7.67
12/21/2007 100 7.67
12/21/2007 100 7.68
12/21/2007 100 7.68
12/21/2007 100 7.69
12/21/2007 100 7.69
12/21/2007 100 7.69
12/21/2007 100 7.69
12/21/2007 100 7.69
12/21/2007 100 7.69
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.7
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.71
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.72
12/21/2007 100 7.73
12/21/2007 100 7.73
12/21/2007 100 7.74
12/21/2007 100 7.74
12/21/2007 100 7.74
12/21/2007 100 7.76
12/21/2007 100 7.76
12/21/2007 100 7.76
12/21/2007 100 7.76
12/21/2007 100 7.76
12/21/2007 150 7.71
12/21/2007 200 7.69
12/21/2007 200 7.7
12/21/2007 200 7.7
12/21/2007 200 7.7
12/21/2007 200 7.7
12/21/2007 200 7.7
12/21/2007 200 7.71
12/21/2007 200 7.71
12/21/2007 200 7.71
12/21/2007 200 7.71
12/21/2007 200 7.71
12/21/2007 200 7.71
12/21/2007 200 7.71
12/21/2007 200 7.71
12/21/2007 200 7.71
12/21/2007 200 7.71
12/21/2007 200 7.71
12/21/2007 200 7.72
12/21/2007 200 7.72
12/21/2007 200 7.72
12/21/2007 200 7.72
12/21/2007 200 7.77
12/21/2007 200 7.77
12/21/2007 250 7.66
12/21/2007 300 7.69
12/21/2007 300 7.7
12/21/2007 300 7.7
12/21/2007 300 7.705
12/21/2007 300 7.71
12/21/2007 300 7.71
12/21/2007 300 7.71
12/21/2007 300 7.71
12/21/2007 300 7.72
12/21/2007 300 7.72
12/21/2007 300 7.72
12/21/2007 300 7.72
12/21/2007 400 7.7
12/21/2007 400 7.71
12/21/2007 400 7.72
12/21/2007 450 7.71
12/21/2007 600 7.69
12/21/2007 600 7.71

Note: All of the above transactions in the Issuer’s Class A Common Stock were effected by Millenco in the open market.